| Histone chaperones: assisting histone traffic and nucleosome dynamics ZA Gurard-Levin, JP Quivy, G Almouzni Annual review of biochemistry 83, 487-517, 2014 | 300 | 2014 |
| A specific function for the histone chaperone NASP to fine-tune a reservoir of soluble H3-H4 in the histone supply chain AJL Cook, ZA Gurard-Levin, I Vassias, G Almouzni Molecular cell 44 (6), 918-927, 2011 | 172 | 2011 |
| High-throughput screening of small molecule libraries using SAMDI mass spectrometry ZA Gurard-Levin, MD Scholle, AH Eisenberg, M Mrksich ACS combinatorial science 13 (4), 347-350, 2011 | 109 | 2011 |
| Peptide arrays identify isoform-selective substrates for profiling endogenous lysine deacetylase activity ZA Gurard-Levin, KA Kilian, J Kim, K Bähr, M Mrksich ACS chemical biology 5 (9), 863-873, 2010 | 103 | 2010 |
| Histone lysine methylation and chromatin replication C Rivera, ZA Gurard-Levin, G Almouzni, A Loyola Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1839 (12 …, 2014 | 100 | 2014 |
| Combining self-assembled monolayers and mass spectrometry for applications in biochips ZA Gurard-Levin, M Mrksich Annu. Rev. Anal. Chem. 1, 767-800, 2008 | 82 | 2008 |
| Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton SC Mwakwari, W Guerrant, V Patil, SI Khan, BL Tekwani, ZA Gurard-Levin, ... Journal of medicinal chemistry 53 (16), 6100-6111, 2010 | 81 | 2010 |
| Combining mass spectrometry and peptide arrays to profile the specificities of histone deacetylases ZA Gurard‐Levin, J Kim, M Mrksich ChemBioChem 10 (13), 2159-2161, 2009 | 78 | 2009 |
| The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma RM de Oca, ZA Gurard-Levin, F Berger, H Rehman, E Martel, A Corpet, ... Molecular oncology 9 (3), 657-674, 2015 | 77 | 2015 |
| Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b F Abascal, A Corpet, ZA Gurard-Levin, D Juan, F Ochsenbein, D Rico, ... Molecular biology and evolution 30 (8), 1853-1866, 2013 | 72 | 2013 |
| The activity of HDAC8 depends on local and distal sequences of its peptide substrates ZA Gurard-Levin, M Mrksich Biochemistry 47 (23), 6242-6250, 2008 | 70 | 2008 |
| High-resolution visualization of H3 variants during replication reveals their controlled recycling C Clément, GA Orsi, A Gatto, E Boyarchuk, A Forest, B Hajj, J Miné-Hattab, ... Nature communications 9 (1), 3181, 2018 | 65 | 2018 |
| Essential role for centromeric factors following p53 loss and oncogenic transformation D Filipescu, M Naughtin, K Podsypanina, V Lejour, L Wilson, ... Genes & development 31 (5), 463-480, 2017 | 59 | 2017 |
| Methylation of histone H3 lysine 9 occurs during translation C Rivera, F Saavedra, F Alvarez, C Díaz-Celis, V Ugalde, J Li, I Forné, ... Nucleic acids research 43 (19), 9097-9106, 2015 | 57 | 2015 |
| Histone modifications and a choice of variant: a language that helps the genome express itself ZA Gurard-Levin, G Almouzni F1000prime reports 6, 2014 | 56 | 2014 |
| Predictive and prognostic value of the tauprotein in breast cancer C Bonneau, ZA Gurard-Levin, F Andre, L Pusztai, R Rouzier Anticancer research 35 (10), 5179-5184, 2015 | 49 | 2015 |
| Photogeneration and reactivity of acyl nitroso compounds AS Evans, AD Cohen, ZA Gurard-Levin, N Kebede, TC Celius, AP Miceli, ... Canadian Journal of Chemistry 89 (2), 130-138, 2011 | 38 | 2011 |
| Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry ZA Gurard-Levin, C Liu, A Jekle, R Jaisinghani, S Ren, K Vandyck, ... Antiviral research 182, 104924, 2020 | 37 | 2020 |
| Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development C Liu, S Boland, MD Scholle, D Bardiot, A Marchand, P Chaltin, LM Blatt, ... Antiviral Research 187, 105020, 2021 | 36 | 2021 |
| A mass spectrometric assay of METTL3/METTL14 methyltransferase activity SM Buker, ZA Gurard-Levin, BD Wheeler, MD Scholle, AW Case, ... SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (4), 361-371, 2020 | 25 | 2020 |
